natural product biosynthesis ͉ enzymology ͉ organohalogen
A large variety of natural products from both terrestrial and marine microorganisms contain covalently attached halogen substituents, predominantly chlorine or bromine (1) . These products include chlorinated nonribosomal peptides such as the vancomycin and teicoplanin family of glycopeptides (2) and aromatic polyketides such as chlorotetracycline (3) . Most of the organochlorine linkages are in aromatic or heteroaromatic rings, such as the 3-Cl-␤-OH-Tyr of the glycopeptides, the chloro substituent in the aminocoumarin antibiotics (2) (3) (4) , and the 4,5-dichloropyrrole in pyoluteorin (5) (Fig.  1A ). There are also aliphatic carbons bearing one, two, or three chlorine atoms in natural products, such as the 4-Cl-L-Thr at residue nine of the peptide scaffold of the phytotoxic syringomycin E from Pseudomonas syringae pv. syringae B301D (6), the dichlorinated ␤-hydroxy acid of lyngbyabellin A (7) , and the trichloroleucine-derived moiety in barbamide (8) (Fig. 1B) . Both the aliphatic and aromatic C-Cl linkages are generated enzymatically.
The timing and mechanism for covalent incorporation of chlorine into these diverse groups of natural products has been unclear, but two lines of information have clarified some of the molecular logic of enzymatic halogenation. The first line has come largely from the isolation and characterization of regioselective tryptophan halogenases from the pyrrolnitrin pathway (9, 10) , the rebeccamycin pathway (11) , and the pyrroindomycin B pathway (12) . This type of halogenase was shown to have a requirement for FADH 2 and O 2 as cofactors (9, 11) . More recently, we have characterized a pyrrole-dichlorinating flavoprotein PltA in the pyoluteorin pathway (P. C. Dorrestein, E. Yeh, S. Garneau, N. L. Kelleher, and C.T.W., unpublished data). Microbial genome sequencing has turned up homologous 50-kDa ORFs with FAD signature binding sites as predicted halogenases in the biosynthetic gene clusters for several nonribosomal peptide and polyketide halogenated metabolites. The general view now is that aromatic and heteroaromatic ring halogenations are effected by such flavoprotein halogenases, although both mechanistic understanding of the active chlorinating species and timing of halogenation relative to peptide chain elongation is still rudimentary.
Halogenation at aliphatic carbon centers of amino acid constituents of nonribosomal peptides appears to use different enzymatic machinery. For example, neither the barbamide synthetase assembly line gene cluster nor the syringomycin synthetase cluster (6, 8) contain obvious flavoprotein halogenase homologs. Instead, they have ORFs predicted to be nonheme Fe II , ␣-ketoglutarate (␣-KG)-requiring enzymes. In this study, we have purified the SyrB1 and SyrB2 components of the syringomycin synthetase from P. syringae (6) (13) . All other chemicals were of analytical grade.
Strains, Media, and Growth. Escherichia coli Top10 (Invitrogen) was used for DNA propagation. E. coli BL21 (DE3) (Invitrogen), transformed with derivatives of pET28b (Novagen), was used for overexpression in LB medium, supplemented with a potassium phosphate buffer described for Terrific Broth (14) . An HClsolubilized solution of minerals (15) Construction of Plasmids and Overexpression of Proteins. DNA was purified, manipulated, and transformed according to standard protocols (14) . The syrB1 and syrB2 genes were amplified from the pJZ514 plasmid. The oligo pairs used for PCR amplification are the following: oSyrB1-for-NdeI 5Ј-GGAATTCCATATGCCGAT-TACGAACACT-3Ј; oSyrB1rev-EcoRI 5Ј-CGGAATTCAT-CAATGGGCTTGAACAAG-3Ј and oSyrB2for-NdeI 5Ј-GGA-ATTCCATATGAGCAAAAAATTCGCC-3Ј oSyrB2rev-EcoRI 5Ј-CGGAATTCATCAGACCGCTTCGAATTT-3Ј. PCR reactions were performed by using the PfuTurbo DNA polymerase (Stratagene) according to the manufacturer's instructions. The resulting amplicons were digested with NdeI and EcoRI and cloned into pET28b (Novagen), yielding the different expression plasmids. The cloned DNA was sequenced to confirm that it contained no errors.
His-tagged Syr proteins were overexpressed in E. coli BL21 (DE3) transformed with their respective plasmids. Two-liter cultures were inoculated with 20 ml of an overnight culture grown at 37°C. The cultures were incubated for 9 h at 25°C, then cooled to 15°C for 1 h before the addition of isopropyl-␤-D-thiogalactopyranoside to a final concentration of 0.5 mM. The cultures were incubated for another 16-17 h, then harvested.
Protein Purification. For SyrB1, a cell pellet from 6 liters of culture was resuspended in buffer A [20 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, pH 8.0͞300 mM NaCl͞5 mM imidazole]. The cells were disrupted by two successive passages through a French press operated at 12,500 psi (1 psi ϭ 6.89 kPa) and 4°C. The cell debris was removed by centrifugation at 27,000 ϫ g for 30 min. The supernatant was carefully removed. This ''raw extract'' was incubated with 4 ml Ni-nitrilotriacetic acid agarose resin (Qiagen) for 1 h and poured in a low-pressure chromatography column (1.5-cm diameter; Bio-Rad). The resin was washed successively with 5 column volumes of buffer A and 4 column volumes of buffer B [20 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid, pH 8.0͞300 mM NaCl͞30 mM imidazole] to remove nonspecifically bound contaminants. SyrB1 was eluted by using buffer C [20 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid pH 8.0͞100 mM NaCl͞200 mM imidazole]. The eluate was concentrated by using Amicon Ultra centrifugal devices (Millipore) and immediately applied to a 26͞60 Superdex 200 column (GE Healthcare) equilibrated with buffer D (20 mM Hepes, pH 7.5). The protein fractions were pooled, concentrated, flash-frozen in liquid N 2 in 10-100-L aliquots, and stored at Ϫ80°C until further use.
For SyrB2, all cell-free preparations were manipulated under an inert atmosphere by using an Mbraun Labmaster glove box (Stratham, NH) maintained at 2 ppm O 2 or less. Chromatography was performed by using an Ä KTA Explorer 100 (GE Healthcare) configured to maintain an anaerobic atmosphere during purification, as described in ref. 15 . Buffers were sparged with Argon and equilibrated in the glove box for 24 h before use. A cell pellet from 6 liters of culture was resuspended and subjected to the French press as described for SyrB1. The broken cells were then sparged with argon for 20 min before transfer in gas-tight tubes in the glove box and centrifugation at 27,000 ϫ g for 30 min. The Ninitrilotriacetic acid column was performed as described for SyrB1 except that it was performed in the glove box. The Ni-nitrilotriacetic acid eluate was concentrated by using Amicon stirred ultrafiltration cells (Millipore) under N 2 pressure. SyrB2 was exchanged into buffer E (20 mM 4-(2-hydroxyethyl)-1-piperazinepropanesulfonic acid pH 8.0͞80 mM NaCl) by a series of concentrations and dilutions in the ultrafiltration cell. Two-millimolar CaCl 2 was added, and the solution was incubated for 3 h at 19°C with thrombin (1 units:10 mg, thrombin:SyrB2). The protein solution was then diluted 1:1 with buffer F (20 mM Tris, pH 8.0) and loaded onto a MonoQ 10͞100GL column (GE Healthcare), equilibrated with buffer F (multiple runs were performed). SyrB2 was eluted by using a NaCl gradient of 150-300 mM over 15 column volumes at a flow rate of 4 ml͞min. Fractions of 2.5 ml were collected and checked for purity by SDS polyacrylamide gels. SyrB2 eluted at Ϸ230 mM NaCl. The fractions were pooled, concentrated, and injected on a 26͞60 Superdex 75 column equilibrated in buffer D. SyrB2 eluted as a monomer. The fractions were pooled, concentrated, flash-frozen in liquid N 2 in 50-100-l aliquots, and stored at Ϫ80°C until further use. Protein concentrations were determined by the Bradford method (17).
Metal Analysis. The metal content of SyrB2 was investigated by using inductively coupled plasma MS performed by Phytronix Technologies (Quebec). In reconstitution experiments, iron concentrations were determined colorimetrically by using FERENE S (18) .
In Vitro Reconstitution of SyrB2. Apo-SyrB2 was reconstituted anaerobically by using two different approaches. In the first approach, SyrB2 was incubated with 1 mM DTT͞0.75 mM Fe(NH 4 ) 2 (SO 4 ) 2 for 30 min before desalting on a Bio-Gel P6DG column (Bio-Rad) equilibrated in 20 mM Hepes (pH 7.5) to remove DTT and excess iron. In the second approach, SyrB2 was incubated with 1 mM DTT͞0.75 mM Fe(NH 4 ) 2 (SO 4 ) 2 ͞2 mM ␣-KG for 30 min before desalting on a Bio-Gel P6DG column equilibrated in 20 mM Hepes, pH 7.5͞2 mM ␣-KG.
ATP-[ 32 P]PPi Exchange
Assay of the A Domain of SyrB1. The ATP-[ 32 P]PPi exchange assay was performed as described in ref. 19 except that 20 mM Hepes (pH 7.5) was used and no Tris(2-carboxyethyl)phosphine was added.
Priming and Self-Loading Assay of SyrB1. The thiolation domain of SyrB1 was posttranslationally modified with the phosphopantetheinyl group by using the purified Sfp protein (20) . For the selfloading assay, SDS polyacrylamide gels of reactions performed in the presence and absence of ATP were done before autoradiography. [ 14 C]Methylated protein standards (GE Healthcare) were coloaded with the broad range standards (Bio-Rad) in the molecular weight standards lanes.
SyrB2 Activity Assays. The reaction catalyzed by SyrB2 was investigated by incubating the enzyme with loaded SyrB1. Loaded SyrB1 was prepared by incubating holo-SyrB1 (100 M) with 2.5 mM
14 C]Thr (20 Ci͞mol) or 2.5 mM L-Thr and 2.5 mM ATP for 60 min, followed by incubation with 2 mM ␣-KG and SyrB2 (6.5 M) for 60 min. Chloride (2.5 mM) was present in the reaction mixture. The resulting reactions were transferred to 0.5 ml Ultrafree cen- trifugal devices equipped with a 10-kDa membrane cutoff (Millipore). Excess amino acids were removed by using four wash steps with 0.5 ml of 20 mM Hepes, pH 7.5. The resulting protein solution was incubated with 5 M of the TycF type II thioesterase (21) to release the loaded amino acids. The amino acids were separated from the proteins by centrifuging the filter devices. The amino acids were then derivatized by using -phthalaldehyde and 3-mercaptopropionate as described in amino acid analysis (22) and analyzed by using HPLC on a Beckman System Gold HPLC equipped with a Beckman 171 radioisotope detector or a Jasco FP-2020 fluorescence detector ( excitation ͞ emission , 340 nm͞450 nm) and compared with authentic standards. The activity of SyrB2 was also investigated on L-Thr and L-Thr-S-N-acetylcysteamine (23) at substrate concentrations of 0.1, 1, and 10 mM with ␣-KG, oxygen, and MgCl 2 present.
␣-KG and Fe Dependency of the SyrB2 Reaction. The ␣-KG dependency of the SyrB2 reaction was investigated by using the Fereconstituted form of SyrB2 in the absence of ␣-KG. The reaction was performed with L-[
14 C]Thr-S-SyrB1 as described in the previous section with 15 M SyrB2 in the absence and presence of 2 mM ␣-KG. For assessing the Fe dependency of the SyrB2 reaction, the apoprotein (14 M) supplemented with 2 mM ␣-KG was used in incubations.
Oxygen Dependency of the SyrB2 Reaction. The oxygen dependency of the SyrB2 reaction was investigated by preparing L-Thr-S-SyrB1 as previously described. L-Thr-S-SyrB1 was brought into the glove box and desalted on a BioGel P6-DG desalting column equilibrated in 20 mM Hepes, pH 7.5. The fractions containing proteins were pooled and divided in 4 aliquots. Two millimolar ␣-KG, 1 mM NaCl and 2.6 M SyrB2 were added to each tube. Two of the tubes were brought out of the box and exposed to air; the other two tubes remained in the glove box for a 60-min incubation. The aerobic and anaerobic reactions were then quenched with the addition of 2 mM 1,10-phenanthroline.
Chloride Dependency of the SyrB2 Reaction. The chloride dependency of the SyrB2 reaction was investigated by using two methods: radio-HPLC and SDS polyacrylamide gels autoradiography by using [ 36 Cl]NaCl. In the first approach, 0.5 ml of 100 M L-Thr-S-SyrB1 was incubated with 1.5 mM ␣-KG, 8 mM [
36 Cl]NaCl (16 mCi͞g Cl), and 14 M SyrB2 and exposed to air for 60 min.
In the second approach, 100 M L-Thr-S-SyrB1 and 100 M holo-SyrB1 were brought into the glove box and desalted on a BioGel P6DG desalting column equilibrated in 20 mM Hepes, pH 7.5. The fractions containing proteins were pooled and incubated with 2 mM ␣-KG, 35 mM [
36 Cl]NaCl (16 mCi͞g Cl), and 15 M SyrB2. A control experiment in which L-Thr-S-SyrB1 was incubated with ␣-KG and [
36 Cl]NaCl, but no SyrB2 was also performed. The reaction mixtures were incubated in air for 60 min before gel loading and autoradiography. [ 14 C]Methylated protein standards (GE Healthcare) were coloaded with the broad range standards (BioRad) in the molecular weight standards lanes. 14 C]KG (18 mCi͞mmol), and 7 M SyrB2 for 1 h. The remaining radioactivity was monitored by using liquid scintillation counting and used to calculate the number of turnovers performed by SyrB2 before inactivation. Control reactions were performed by omitting L-Thr-S-SyrB1 or SyrB2 in the mixture.
Liquid Chromatography (LC)-MS Analysis.
The masses of the released L-Thr and 4-Cl-L-Thr from SyrB1 by using TycF were monitored after derivatization with -phthalaldehyde and 3-mercaptopropionate. Three hundred-microliter reactions of 100 M SyrB1 were performed with or without SyrB2. The amino acids were hydrolyzed as previously described and analyzed by LC-MS (positive mode).
Results
Expression and Purification of SyrB1 and SyrB2. The syrB1 and syrB2 genes from the P. syringae syringomycin biosynthetic cluster were expressed in E. coli as His-tagged fusions and purified as soluble proteins, with yields of 30 mg for SyrB1 and 10-12 mg for SyrB2 per liter of bacterial culture. SDS polyacrylamide gels indicated Ͼ95% and 99% purity, respectively.
Because we anticipated SyrB2 would be an oxygen-labile Fe II enzyme, the crude extract was immediately kept under N 2 gas and transferred to an anaerobic glove box for purification and storage. The purified SyrB2 was an apoprotein and the His-tag was removed by proteolytic cleavage and chromatography to yield an enzyme that was then subjected to anaerobic reconstitution with Fe II . In the absence of added ␣-KG, SyrB2 had 0.3-0.4 equivalents of bound Fe II after anaerobic gel filtration. When ␣-KG was included in the reconstitution mixture, SyrB2 contained 0.85 to 0.95 equivalents of 
Fe
II after gel filtration, consistent with the prediction it is an ␣-KGand Fe II -requiring enzyme.
Characterization of SyrB1 Activity. SyrB1 is a 66-kDa didomain protein, consisting of an adenylation (A) domain and a thiolation (T) domain. Previous studies had indicated it could activate L-Thr (6) and led to the conclusion that SyrB1 selects and activates Thr-9 in the syringomycin backbone. For our purposes, we wanted to confirm that SyrB1 would show selectivity for L-Thr over 4-Cl-L-Thr as would be anticipated if chlorination occurred after covalent loading and formation of L-Thr-S-SyrB1. The first half-reaction of the A domain, reversible formation of L-Thr-AMP, was followed by amino acid-dependent exchange of [ 32 PPi] into ATP. In the presence of 5 mM amino acid, the relative rates were obtained as follows: L-Thr (100 Ϯ 3.6%), L-Ser (3.1 Ϯ 0.1%), 4-Cl-L-Thr (1.14 Ϯ 0.01%), D-Thr (1.01 Ϯ 0.01%), L-Ile (0.40 Ϯ 0.01%), L-Leu (0.33 Ϯ 0.01%), and D-Ser (0.24 Ϯ 0.04%). All other proteinogenic L-amino acids were tested and showed a rate of 0.25% or less when compared with L-Thr. The high specificity of SyrB1 for L-Thr was confirmed by a 60-fold selectivity in the apparent kinetic parameters for L-Thr (K m ϭ 3.1 Ϯ 0.2 mM; k cat ϭ 29.1 Ϯ 0.9 min
. Most notably, SyrB1 shows low ability to activate 4-Cl-L-Thr, consistent with chlorination downstream of amino acid activation.
The second half-reaction of SyrB1 should be the transfer of the activated threonyl moiety in L-Thr-AMP to the phosphopantetheinyl moiety on the T domain (Fig. 2A) . The holo form (phosphopantetheinylated) of the T domain was generated posttranslationally in situ through action of Sfp (20) and aspartate as putative ligands for Fe II (26) (27) . The formation of the Fe IV AO ferryl species is likely to be a common intermediate in both the oxygenase and halogenase mechanism. The high-valent oxoiron species can break unactivated C-H bonds in substrates homolytically to produce the substrate radical and an Fe III -OH as donor of an OH⅐ by radical rebound to complete hydroxylation (24, 25, 28) . We anticipate that there will be a chloride ion bound to the Fe IV intermediate of the SyrB2 active site. After C-H homolysis at carbon 4 of the threonyl moiety of L-Thr-S-SyrB1, there could be a competition between transfer of OH⅐ or Cl⅐ to the threonyl CH 2 ⅐ . Because no hydroxylation is detected (data not shown), we assume an orientation favoring Cl⅐ transfer. A favored reactivity toward chlorination could also be due to the lower potential of Cl⅐ vs. OH⅐ (29) . This proposed enzyme chemistry has precedent in two model systems where transfers of metal-coordinated Cl⅐ have been formulated: chromyl chloride-mediated chlorination of cyclohexane (30, 31) and, perhaps of even closer relevance, the chlorination of cyclohexane by a nonheme Fe-Cl reagent (29) . The SyrB2 enzyme is generating reactive intermediates because the enzyme is inactivated after approximately seven catalytic cycles under the reaction conditions.
SyrB2 will not chlorinate free L-Thr or the threonyl moiety presented as the model thioester, L-Thr-S-N-acetylcysteamine, suggesting a strong recognition of the presenting T domain scaffold. This preference suggests the in vivo timing of SyrB2 is indeed to tailor the threonyl moiety while on SyrB1. Presumably, 4-Cl-L-Thr-S-SyrB1 is then the immediate donor to the growing octapeptidyl-S-SyrE and incorporated as the Cl-Thr-9 found in mature syringomycin (6) . We have recently reported that PltA is analogously a tailoring halogenase during elongation of a pyrrolyl-S-T domain during pyoluteorin formation by the hybrid nonribosomal peptide synthetase͞polyketide synthase assembly line (P. C. Dorrestein, E. Yeh, S. Garneau, N. L. Kelleher, and C.T.W., unpublished data). In that case, PltA is an FADH 2 -and O 2 -dependent halogenase rather than an ␣-KG-and O 2 -dependent nonheme Fe II halogenase. The timing of chlorination, of acyl and aminoacyl substrates presented on carrier domain proteins, may be general for other halogenated nonribosomal peptide and polyketide natural products, e.g., in the vancomycin family of chlorinated glycopeptide antibiotics (2) .
Although attention has focused in recent years on the FADH 2 -and O 2 -dependent class of halogenases as the biosynthetically relevant halogenases for natural products because they are encoded within many biosynthetic gene clusters, the flavoprotein halogenases work primarily on activated aromatic and heteroaromatic rings of natural product scaffolds (9-12). They may not generally have the oxidizing͞halogenating power to functionalize unactivated carbon centers.
In this regard, nature usually turns to high-valent oxoiron, both in heme and nonheme contexts (24, 26, 32) , to hydroxylate unactivated methyl and methylene groups. This type of reaction may be the chemical niche for nonheme Fe II halogenases. It is very likely that a second example of this nonheme Fe II halogenase class is the BarbB1͞B2 pair, implicated in functionalizing the unactivated methyl group of a L-Leu moiety during trichloroleucine formation as a building block in barbamide biosynthesis (8) . Thus, a subclass of the nonheme Fe II ␣-KG-dependent superfamily may use ␣-KG and O 2 to generate high-valent oxoiron species but divert them for halogenation, rather than hydroxylation, of many unactivated carbon centers in the Ͼ4,000 chlorinated and brominated natural products. Deciphering how the diversion from hydroxylation to halogenation occurs during natural product maturation remains a significant challenge.
